120 related articles for article (PubMed ID: 27175928)
21. Compounding in Ukraine.
Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
[TBL] [Abstract][Full Text] [Related]
22. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program.
Griffiths T; Connors A
Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174
[TBL] [Abstract][Full Text] [Related]
23. GMPs vs GCPs: United States Pharmacopeia General Chapters.
Allen LV
Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
[No Abstract] [Full Text] [Related]
24. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
[TBL] [Abstract][Full Text] [Related]
25. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
26. Implementing United States Pharmacopeia Chapter <1163> quality assurance in pharmaceutical compounding, Part 5: Outsourcing and responsible personnel.
Allen LV
Int J Pharm Compd; 2012; 16(6):490-6. PubMed ID: 23259367
[TBL] [Abstract][Full Text] [Related]
27. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
Vu N; Nguyen K; Kupiec TC
Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
[TBL] [Abstract][Full Text] [Related]
28. Practice parameters for allergen immunotherapy. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology.
J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1001-11. PubMed ID: 8977497
[No Abstract] [Full Text] [Related]
29. Compounding bevacizumab for intravitreal injection: does USP <797> always apply?
Shienbaum G; Flynn HW
Retina; 2013 Oct; 33(9):1733-4. PubMed ID: 23851633
[No Abstract] [Full Text] [Related]
30. PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives.
Allen LV
Int J Pharm Compd; 2017; 21(3):180. PubMed ID: 28557778
[No Abstract] [Full Text] [Related]
31. [Cluster immunotherapy in allergic rhinoconjunctivitis: review of a new therapeutic approach].
Pfaar O; Klimek L
Hautarzt; 2006 Oct; 57(10):875-80. PubMed ID: 16969674
[TBL] [Abstract][Full Text] [Related]
32. Rules and regulations for the production of allergenic extracts: past, present, future.
Brede HD
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1985; (79):3-9. PubMed ID: 4051495
[No Abstract] [Full Text] [Related]
33. Preventing medication errors with nimodipine by compounding proper dosage forms.
McElhiney LF
Int J Pharm Compd; 2013; 17(5):364-8. PubMed ID: 24459780
[TBL] [Abstract][Full Text] [Related]
34. Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging.
Allen LV
Int J Pharm Compd; 2012; 16(5):405-14. PubMed ID: 23072201
[TBL] [Abstract][Full Text] [Related]
35. New England Compounding Center Indictment.
Cabaleiro J
Int J Pharm Compd; 2015; 19(2):94-102. PubMed ID: 26685489
[TBL] [Abstract][Full Text] [Related]
36. USP releases revision of chapter on sterile compounding: new version of USP chapter 797 emphasizes personnel.
Thompson CA
Am J Health Syst Pharm; 2008 Jan; 65(2):104, 111. PubMed ID: 18192250
[No Abstract] [Full Text] [Related]
37. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
38. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
Allen LV
Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
[TBL] [Abstract][Full Text] [Related]
39. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
[TBL] [Abstract][Full Text] [Related]
40. Payer database and geospatial analysis to evaluate practice patterns in treating allergy in North Carolina.
Crowson MG; Schulz K; Ulvila A; Witsell DL
Am J Otolaryngol; 2018; 39(1):20-24. PubMed ID: 29031937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
